ESTEVE CDMO Acquires Chicago-Based Regis Technologies to Expand US Manufacturing Capabilities
Key Insights
ESTEVE (search) CDMO has acquired Regis Technologies (search), a 65-year-old Chicago-based contract development and manufacturing organization, establishing its first physical presence in the United States.
The acquisition expands ESTEVE (search)'s contract development and manufacturing solutions for small-molecule active pharmaceutical ingredients (search) across the entire drug development lifecycle from pre-clinical to commercial manufacturing.
Regis Technologies (search) brings approximately 70 skilled professionals and comprehensive services including process research & development, analytical & stability testing, cGMP API manufacturing, and chromatography products.
ESTEVE (search) CDMO has completed the acquisition of Regis Technologies (search), a United States-based Contract Development and Manufacturing Organization (CDMO) headquartered in Chicago, marking a significant expansion of the Spanish pharmaceutical company's global manufacturing capabilities. The strategic acquisition establishes ESTEVE's first physical presence in the United States and expands its contract development and manufacturing solutions for innovative small-molecule active pharmaceutical ingredients (search) (APIs) across the entire drug development lifecycle from pre-clinical to commercial manufacturing.
Strategic Expansion into US Market
The acquisition allows ESTEVE (search) CDMO, which operates under the Esteve Química (search) brand, to strengthen its position as a global pure-play third-party CDMO specializing in high-quality small-molecule active pharmaceutical ingredients (search) and pharmaceutical intermediates. The company provides advanced technologies including Spray Drying and high-potency APIs (search) (HPAPIs) manufacturing.
"We are proud to strengthen our CDMO solutions for pharmaceutical innovators through this acquisition, while welcoming around 70 skilled professionals to our US team," said Joan Petit, Chief Industrial Operations Officer of ESTEVE (search) and General Manager of Esteve CDMO (Esteve Química (search)).
Comprehensive Service Portfolio
Regis Technologies (search) brings over 65 years of experience as a US-based API CDMO, offering a broad spectrum of services that complement ESTEVE (search)'s existing capabilities. The acquired company provides process research & development, analytical & stability testing, cGMP API manufacturing, CMC support, and a variety of chromatography products. The company's facilities undergo routine inspections by the FDA and other global regulatory authorities.
Andrea Oro, Global Head of Commercial Operations and Strategy at ESTEVE (search), emphasized the strategic value of the acquisition: "This acquisition enhances our early-stage development capabilities, and expands our global manufacturing footprint, allowing us to have an integrated service offering to better respond to our customers' needs."
Shared Values and Cultural Alignment
The acquisition represents a union of two family-owned companies with complementary values and extensive industry experience. Scott Aladeen, President and CEO of Regis Technologies (search), highlighted the cultural alignment: "We are happy to join a company that shares our same values, a company that is also family-owned, with more than 90 years of experience, that is committed to people and focused on delivering long-term value to customers."
Founded in 1956 by Dr. Louis Glunz III in Chicago, Regis Technologies (search) has remained privately owned and operated throughout its history. The company partners with pharmaceutical and biotechnology companies to advance drug candidates to market, streamlining and supporting discovery, lead molecule development, and drug commercialization processes.
Global Manufacturing Network
ESTEVE (search), founded in 1929 and headquartered in Barcelona, maintains a strong international presence with pharmaceutical affiliates in Spain, Portugal, Italy, Germany, France, the UK, and the USA. The company's comprehensive Contract Manufacturing and Development services operate through world-class facilities in Spain, Mexico, and China, with the Regis Technologies (search) acquisition now adding US-based capabilities to this global network.
The transaction was facilitated by RBC Capital Markets (search), which served as financial advisor for ESTEVE (search), while Wombat Capital Markets (search) advised Regis Technologies (search) on the deal.